Literature DB >> 9718833

Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995.

H Laurichesse1, O Grimaud, P Waight, A P Johnson, R C George, E Miller.   

Abstract

A total of 10,346 blood and 682 cerebrospinal fluid (CSF) isolates of Streptococcus pneumoniae were reported to the PHLS Communicable Disease Surveillance Centre from laboratories in England and Wales from 1 January 1993 to 31 December 1995. This corresponds to a mean annual incidence of 6.7 per 100,000 episodes of bacteraemia and 0.44/100,000 of meningitis. Absolute numbers of pneumococcal bacteraemia were similar to levels reported between 1990 and 1992, but fewer isolates of pneumococci were made from CSF. There was no discernible overall trend between 1993 and 1995, but age specific incidence suggested a slight increase in bacteraemia in older age groups. Estimated case fatality rates were 20% for pneumococcal bacteraemia and 22% for meningitis. The proportion of pneumococcal strains resistant to penicillin and erythromycin rose between 1989 and 1995 from 0.3% to 2.9% and 3.3% to 10.9%, respectively. The persistent threat of invasive pneumococcal infections highlights the need for continuing laboratory surveillance (including serotyping), appropriate use of antibiotics, and immunisation of groups at risk. The development of conjugate vaccines offers new prospects for prevention.

Entities:  

Mesh:

Year:  1998        PMID: 9718833

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  19 in total

1.  Family doctor advice is the main determinant of pneumococcal vaccine uptake.

Authors:  M H Kyaw; J S Nguyen-Van-Tam; J C Pearson
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

Review 2.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 3.  Antibiotic resistance: a current perspective.

Authors:  K F Barker
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

4.  Clinical training experience in district general hospitals.

Authors:  R MacFaul; S Jones; U Werneke
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

Review 5.  The epidemiology of acute meningitis in children in England and Wales.

Authors:  K L Davison; M E Ramsay
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

6.  Incidence and outcome of pneumococcal meningitis in northern England.

Authors:  N C Weightman; J Sajith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

7.  Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.

Authors:  M H Reacher; A Shah; D M Livermore; M C Wale; C Graham; A P Johnson; H Heine; M A Monnickendam; K F Barker; D James; R C George
Journal:  BMJ       Date:  2000-01-22

8.  Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.

Authors:  Qibo Zhang; Sharon Choo; Adam Finn
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.

Authors:  P Ispahani; R C B Slack; F E Donald; V C Weston; N Rutter
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

10.  Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.

Authors:  C A Ihekweazu; D A B Dance; R Pebody; R C George; M D Smith; P Waight; H Christensen; K A V Cartwright; J M Stuart
Journal:  Epidemiol Infect       Date:  2007-10-26       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.